PI3Kδ-IN-7n

CAS No. 2088525-31-7

PI3Kδ-IN-7n( —— )

Catalog No. M13260 CAS No. 2088525-31-7

PI3Kδ-IN-7n is a highly potent and selective PI3Kδ inhibitor with IC50 of 0.9 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 150 In Stock
10MG 226 In Stock
25MG 372 In Stock
50MG 498 In Stock
100MG 681 In Stock
200MG 917 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PI3Kδ-IN-7n
  • Note
    Research use only, not for human use.
  • Brief Description
    PI3Kδ-IN-7n is a highly potent and selective PI3Kδ inhibitor with IC50 of 0.9 nM.
  • Description
    PI3Kδ-IN-7n is a highly potent and selective PI3Kδ inhibitor with IC50 of 0.9 nM, displays high selectivity (>1,500-fold) over PI3Kα, PI3Kβ, PI3Kγ (IC50>1.5 uM); shows reasonable pharmacokinetics with good bioavailability and moderate in vivo half-life; one of the most selective PI3Kδ inhibitors published to date.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3K
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2088525-31-7
  • Formula Weight
    429.459
  • Molecular Formula
    C23H20FN7O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    4-(3-amino-6-(1-methyl-5-(1-phenylcyclopropyl)-1H-1,2,4-triazol-3-yl)pyrazin-2-yl)-2-fluorobenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Terstiege I, et al. Bioorg Med Chem Lett. 2017 Feb 1;27(3):679-687.
molnova catalog
related products
  • LY3023414

    LY3023414 is a potent, dual PI3K/mTOR inhibitor.

  • GSK251

    GSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.

  • B591

    B591 (B-591) is a potent, specific pan-PI3K inhibitor with IC50 of 1.3/0.36/1.1/1.58 uM for PI3Kα/β/γ/δ, respectively.